Labeling Peptide Nucleic Acids with Indium-111.

Area of Science:

• Bioconjugation Chemistry
• Radiopharmaceutical Development
• Molecular Biology

Background:

• Peptide nucleic acids (PNA) are synthetic DNA mimics with high binding specificity.
• PNAs are explored for gene-targeted radiotherapeutics to deliver localized DNA/RNA damage.
• Efficient incorporation of radionuclides into PNAs is crucial for therapeutic applications.

Purpose of the Study:

• To establish a procedure for incorporating the gamma-emitting radionuclide ¹¹¹In into PNA oligomers.
• To enable the development of ¹¹¹In-labeled PNAs for potential gene-targeted radiotherapies.
• To demonstrate the feasibility of radiolabeling PNA constructs.

Main Methods:

• Conjugation of diethylenetriaminepentaacetic acid (DTPA) to a lysine-containing mixed-base PNA.
• Chelation of the PNA-DTPA conjugate with ¹¹¹In³⁺.
• Acidic aqueous solution conditions for radiolabeling.

Main Results:

• Successful incorporation of ¹¹¹In into PNA oligomers was achieved.
• ¹¹¹In-labeled PNA-DTPA conjugates were synthesized.
• The described method provides a route for creating targeted radiotherapeutic agents.

Conclusions:

• A straightforward method for ¹¹¹In radiolabeling of PNA oligomers is presented.
• This technique facilitates the creation of PNA-based radiopharmaceuticals for targeted therapy.
• ¹¹¹In-labeled PNAs hold promise for precise delivery of radiodamage to specific nucleic acid sites.